Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 5 subfamily G member 3 (OR5G3) is a member of the olfactory receptor gene family, which encodes G protein-coupled receptors (GPCRs) responsible for detecting odorant molecules in the nasal epithelium and initiating neuronal signaling that triggers the perception of smell[5][2][3][4]. These receptors work by binding a range of odorant ligands and activating intracellular signaling cascades via olfactory G proteins, leading to the generation of an action potential conveying olfactory information to the brain[2][5]. However, OR5G3 is annotated as a pseudogene in humans, with no known evidence of functional protein expression or involvement in therapeutic targeting, drug interactions, or established disease roles[5]. Key points: - Olfactory receptors—like OR5G3—belong to Class A GPCRs, characterized by a 7-transmembrane domain structure, and are the largest family of GPCRs in the human genome[5][3]. - These are primarily involved in chemosensory perception (olfaction) and signal transduction through cAMP pathways[2]. - OR5G3 is considered a pseudogene in humans, meaning it is not known to produce a functional protein or serve as a viable therapeutic target[5]. - There are currently no known interacting drugs, clinical biomarkers, or safety concerns associated with OR5G3, nor evidence for involvement in major disease categories. Note: - Entries related to "OR5G3P, OR5G6P, olfactory receptor, family 5, subfamily G, member 3 pseudogene," reflect its status as a pseudogene. - The entry is considered incorrect as a viable therapeutic target for drug discovery or clinical research, given the lack of functional expression and biological annotation beyond olfactory detection[5]. If a functional olfactory receptor gene from the same family is of interest, please specify, as this entry does not encode an active protein product or serve a role in current biomedical targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 5 subfamily G member 3 (OR5G3).